Evaluation of Pars Plana Vitrectomy With Internal Limiting Membrane Peeling for Myopic Traction Maculopathy
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Tanta University
- Enrollment
- 52
- Primary Endpoint
- Improvement of best corrected visual acuity
Study Overview
Brief Summary
Investigate the effectiveness and safety of pars plans vitrectomy, with internal limiting membrane peeling for cases of myopic traction maculopathy
Detailed Description
Performing pars plana vitrectomy for highly myopic patients with decreased visual acuity is the standard of care for patients with myopic traction. A variety of findings are seen by Optical Coherence Tomography. Epiretinal membranes, retinoschisis, lamellar macular holes, and full thickness macular holes are seen. Undergoing vitrectomy, with or without tamponade, in our center, is retrospectively evaluated. Visual acuity change, as well as improvement of the retinal structure by OCT will be examined.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 30 Years to 60 Years (Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Highly myopic patients, having a refractive errors (spherical equivalent) of more than - 8 Diopter, or an axial length more than 26.5 mm.
- •Best Corrected Visual Acuity less than 0.1
- •Spectral Domain Optical Coherence Tomography showed; staphylomatous changes, with either: Macular retinoschisis, foveal retinal detachment, full thickness macular hole (with or without macualr hole retinal detachment), or lamellar macular hole, with epiretinal membrane
- •At least 6 months follow-up
Exclusion Criteria
- •Eyes with diffuse chorioretinal macular atrophy
- •Concomitant presence of a choroidal neovascular membrane
- •Young patients less than 21 years old.
- •History of trauma
- •Dense media opacity (corneal/ lenticular)
Outcomes
Primary Outcomes
Improvement of best corrected visual acuity
Time Frame: 6 months
Secondary Outcomes
No secondary outcomes reported
Investigators
Sharif Yousef El Emam
Clinical Associate Professor
Tanta University